Lutter Named to Top Policy Role at FDA

FDA Commissioner Andrew von Eschenbach has named Randall Lutter, PhD, to be acting deputy commissioner for policy. He replaces Scott Gottlieb, who recently resigned. Lutter had been Associate Commissioner for Policy and Planning, and before that was chief economist in the Office of Planning. In his new role, he will serve as lead advisor to von Eschenbach on agency policy.DeviceTalk will return on Wednesday, December 27.

December 22, 2006

1 Min Read
Lutter Named to Top Policy Role at FDA

FDA Commissioner Andrew von Eschenbach has named Randall Lutter, PhD, to be acting deputy commissioner for policy. He replaces Scott Gottlieb, who recently resigned. Lutter had been Associate Commissioner for Policy and Planning, and before that was chief economist in the Office of Planning. In his new role, he will serve as lead advisor to von Eschenbach on agency policy.DeviceTalk will return on Wednesday, December 27.

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like